Ivan Benaduce Casella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ivan Benaduce Casella has a total of 560 co-authors. Here are the top co-authors by number of shared publications:
Calógero Presti
Vascular Surgery Division, Department of Surgery, Clinic's Hospital, Faculty of Medicine, University of São Paulo, São Paulo, Brazil
11 shared publications- Pedro Puech-Leão
Department of Vascular Surgery, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
10 shared publications - Marcone Lima Sobreira
Universidade Estadual Paulista
4 shared publications - Marcos Arêas Marques
Universidade Federal do Estado do Rio de Janeiro, Brasil; Universidade do Estado do Rio de Janeiro, Brasil
4 shared publications - Rafael de Athayde Soares
Division of Vascular and Endovascular Surgery, Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil
4 shared publications - Edwaldo Edner Joviliano
Universidade de São Paulo, Brazil
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Elsevier in Annals of Vascular Surgery
Novel Ultrasound Parameters for the Stratification of Femoropopliteal Artery Lesions: A B-Mode and Acceleration Rate Approach
- 10 November 2026
- Published by Elsevier in Annals of Vascular Surgery
Open AccessNovel Ultrasound Parameters for the Stratification of Femoropopliteal Artery Lesions: A B-Mode and Acceleration Rate Approach
- 1 August 2025
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 44 (4)
Role of carotid plaque analysis in therapeutic decision-making for carotid disease
Carotid atherosclerosis is an important yet declining etiology of embolic stroke and cerebrovascular or retinal ischemic events with an embolic source. The severity of stenosis is the most important anatomic factor for deciding whether to use optimized medical therapy alone or interventional therapy. Recently, specific features of the atherosclerotic plaque have attracted increasing attention; for example, total plaque area, juxtaluminal black area, intraplaque hemorrhage, and mainly echolucent plaques are associated with high risk of late stroke, and these features now influence the therapeutic choices. This review describes the current state of carotid plaque analysis using different image modalities and its effect on current guidelines and clinical practice.
- 1 August 2025
- Published by Edizioni Minerva Medica in International Angiology
- Vol. 44 (4)
Role of carotid plaque analysis in therapeutic decision-making for carotid disease
Carotid atherosclerosis is an important yet declining etiology of embolic stroke and cerebrovascular or retinal ischemic events with an embolic source. The severity of stenosis is the most important anatomic factor for deciding whether to use optimized medical therapy alone or interventional therapy. Recently, specific features of the atherosclerotic plaque have attracted increasing attention; for example, total plaque area, juxtaluminal black area, intraplaque hemorrhage, and mainly echolucent plaques are associated with high risk of late stroke, and these features now influence the therapeutic choices. This review describes the current state of carotid plaque analysis using different image modalities and its effect on current guidelines and clinical practice.
- 17 January 2024
- Published by Wiley in Transfusion
- Vol. 64 (3) , 546-549
A rare vascular injury in a blood donor after whole blood donation
BackgroundBlood donation is a safe process though reactions may still occur. We describe a rare vascular complication in a frequent donor, with improvements in the collection process aimed at avoiding future events.MethodsA 63-year-old woman presented with local pain and an apparent collection in the left arm 8 days after donation. Duplex ultrasound identified a superficial liquid collection and signs of arteriovenous fistula (AVF) between the cubital vein and an arterial branch. A computed tomography (CT)-angio performed 1 day after ultrasound did not identify signs of AVF, followed by a new duplex which confirmed CT-angio findings. It was assumed that a traumatic AVF evolved with spontaneous thrombosis. In the early follow-up (18 days), a progressive regression of hematoma was observed without any sequelae.ResultsInvestigation showed a faster whole blood bag collection time (3 min; normal: 5-9 min), and the processed packed red blood cell had a brighter red color than usual. The donor reported local bleeding after needle withdrawal, not observed in previous donations and a bruise forming on the same day. No arterial puncture (AP) was noticed by the collection staff during the procedure. The staff was retrained and actions were taken focusing on more active surveillance of late reactions, highlighting the importance of post-donation information by the donors, regardless of any adverse reaction observed, to detect late complications.ConclusionWe described an uncommon AP in a donor that was not identified, leading to an AVF that spontaneously thrombosed.
- 17 January 2024
- Published by Wiley in Transfusion
- Vol. 64 (3) , 546-549
A rare vascular injury in a blood donor after whole blood donation
BackgroundBlood donation is a safe process though reactions may still occur. We describe a rare vascular complication in a frequent donor, with improvements in the collection process aimed at avoiding future events.MethodsA 63-year-old woman presented with local pain and an apparent collection in the left arm 8 days after donation. Duplex ultrasound identified a superficial liquid collection and signs of arteriovenous fistula (AVF) between the cubital vein and an arterial branch. A computed tomography (CT)-angio performed 1 day after ultrasound did not identify signs of AVF, followed by a new duplex which confirmed CT-angio findings. It was assumed that a traumatic AVF evolved with spontaneous thrombosis. In the early follow-up (18 days), a progressive regression of hematoma was observed without any sequelae.ResultsInvestigation showed a faster whole blood bag collection time (3 min; normal: 5-9 min), and the processed packed red blood cell had a brighter red color than usual. The donor reported local bleeding after needle withdrawal, not observed in previous donations and a bruise forming on the same day. No arterial puncture (AP) was noticed by the collection staff during the procedure. The staff was retrained and actions were taken focusing on more active surveillance of late reactions, highlighting the importance of post-donation information by the donors, regardless of any adverse reaction observed, to detect late complications.ConclusionWe described an uncommon AP in a donor that was not identified, leading to an AVF that spontaneously thrombosed.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 23, e20230107
Diretrizes sobre trombose venosa profunda da Sociedade Brasileira de Angiologia e Cirurgia Vascular
Resumo Trombose venosa profunda é uma das principais causas de morbidade hospitalar e ambulatorial, seja em pacientes clínicos, seja em pacientes cirúrgicos, impactando significativamente nas estatísticas de mortalidade, exigindo um diagnóstico rápido para que se institua de forma imediata o tratamento. O presente documento foi preparado e revisado por onze especialistas certificados pela Sociedade Brasileira de Angiologia e Cirurgia Vascular, que buscaram nas principais bases de dados as melhores evidências referentes à abordagem diagnóstica (exame físico, exames de imagem) e terapêutica (heparina, cumarínicos, anticoagulantes orais de ação direita, fibrinolíticos) da doença.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 23, e20230107
Open AccessDiretrizes sobre trombose venosa profunda da Sociedade Brasileira de Angiologia e Cirurgia Vascular
Resumo Trombose venosa profunda é uma das principais causas de morbidade hospitalar e ambulatorial, seja em pacientes clínicos, seja em pacientes cirúrgicos, impactando significativamente nas estatísticas de mortalidade, exigindo um diagnóstico rápido para que se institua de forma imediata o tratamento. O presente documento foi preparado e revisado por onze especialistas certificados pela Sociedade Brasileira de Angiologia e Cirurgia Vascular, que buscaram nas principais bases de dados as melhores evidências referentes à abordagem diagnóstica (exame físico, exames de imagem) e terapêutica (heparina, cumarínicos, anticoagulantes orais de ação direita, fibrinolíticos) da doença.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 23, e20230107
Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery
Deep vein thrombosis is one of the main causes of inpatient and outpatient morbidity, both in medical and surgical patients, significantly impacting mortality statistics and requiring prompt diagnosis so that treatment can be initiated immediately. This document was prepared and reviewed by 11 specialists certified by the Brazilian Society of Angiology and Vascular Surgery, who searched the main databases for the best evidence on the diagnostic (physical examination, imaging) and therapeutic approaches (heparin, coumarins, direct oral anticoagulants, fibrinolytics) to the disease.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 23, e20230107
Open AccessGuidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery
Deep vein thrombosis is one of the main causes of inpatient and outpatient morbidity, both in medical and surgical patients, significantly impacting mortality statistics and requiring prompt diagnosis so that treatment can be initiated immediately. This document was prepared and reviewed by 11 specialists certified by the Brazilian Society of Angiology and Vascular Surgery, who searched the main databases for the best evidence on the diagnostic (physical examination, imaging) and therapeutic approaches (heparin, coumarins, direct oral anticoagulants, fibrinolytics) to the disease.
- Open Access
- 1 January 2024
- Vol. 23, e20230094
Brazilian Angiology and Vascular Surgery Society Guidelines for the treatment of extracranial cerebrovascular disease
Extracranial cerebrovascular disease has been the subject of intense research throughout the world, and is of paramount importance for vascular surgeons. This guideline, written by the Brazilian Society of Angiology and Vascular Surgery (SBACV), supersedes the 2015 guideline. Non-atherosclerotic carotid artery diseases were not included in this document. The purpose of this guideline is to bring together the most robust evidence in this area in order to help specialists in the treatment decision-making process. The AGREE II methodology and the European Society of Cardiology system were used for recommendations and levels of evidence. The recommendations were graded from I to III, and levels of evidence were classified as A, B, or C. This guideline is divided into 11 chapters dealing with the various aspects of extracranial cerebrovascular disease: diagnosis, treatments and complications, based on up-to-date knowledge and the recommendations proposed by SBACV.
- 1 January 2024
- Vol. 23, e20230094
Open AccessBrazilian Angiology and Vascular Surgery Society Guidelines for the treatment of extracranial cerebrovascular disease
Extracranial cerebrovascular disease has been the subject of intense research throughout the world, and is of paramount importance for vascular surgeons. This guideline, written by the Brazilian Society of Angiology and Vascular Surgery (SBACV), supersedes the 2015 guideline. Non-atherosclerotic carotid artery diseases were not included in this document. The purpose of this guideline is to bring together the most robust evidence in this area in order to help specialists in the treatment decision-making process. The AGREE II methodology and the European Society of Cardiology system were used for recommendations and levels of evidence. The recommendations were graded from I to III, and levels of evidence were classified as A, B, or C. This guideline is divided into 11 chapters dealing with the various aspects of extracranial cerebrovascular disease: diagnosis, treatments and complications, based on up-to-date knowledge and the recommendations proposed by SBACV.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20220101
Double-edged sword effect of platelets in COVID-19
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 22, e20220101
Open AccessDouble-edged sword effect of platelets in COVID-19
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 20
Vacinas para covid-19 e complicações tromboembólicas
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 20
Open AccessVacinas para covid-19 e complicações tromboembólicas
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 19
Fisiopatologia da trombose associada à infecção pelo SARS-CoV-2
Este editorial tem a modesta pretensão de apresentar as teorias e evidências científicas acerca da fisiopatologia dos processos trombóticos associados à infecção pelo SARS-CoV-2. No entanto, há alguns aspectos importantes a serem realçados: parte das explicações cientificas ainda se encontram no campo das hipóteses; os processos patológicos observados são predominantemente concomitantes e se estimulam mutuamente; ainda é difícil quantificar o impacto isolado de eventos que ocorrem em escala molecular e celular nos desfechos clínicos finais do evento trombótico.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Jornal Vascular Brasileiro
- Vol. 19
Open AccessFisiopatologia da trombose associada à infecção pelo SARS-CoV-2
Este editorial tem a modesta pretensão de apresentar as teorias e evidências científicas acerca da fisiopatologia dos processos trombóticos associados à infecção pelo SARS-CoV-2. No entanto, há alguns aspectos importantes a serem realçados: parte das explicações cientificas ainda se encontram no campo das hipóteses; os processos patológicos observados são predominantemente concomitantes e se estimulam mutuamente; ainda é difícil quantificar o impacto isolado de eventos que ocorrem em escala molecular e celular nos desfechos clínicos finais do evento trombótico.